You mean no reason apart from lowered guidance, poor outlook and poor acquisition strategy? (Yes I'm shorting ANN.)
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025